Baidu
map
FRONT CARDIOVASC MED 润色咨询

Frontiers in Cardiovascular Medicine

出版年份：暂无数据 年文章数：3784 投稿命中率： 开通期刊会员，数据随心看

出版周期：C 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2024-05-10 12524002m39暂无昵称 来自北京

    被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2022-06-16 ms3720148795955021

    今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！

    16

    展开16条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2024-06-26 ms5000001250467069 来自江西省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：心血管
    经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2024-01-21 ms2000000620153331 来自陕西省

    23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2022-07-22 1259390fm84暂无昵称

    见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2023-08-22 ms6000001243617632 来自湖北省

    大家都推荐审稿人了么，是不是没推就会慢很多

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2023-09-04 ms2000000203298966 来自浙江省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向：心血管;冠心病
    经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2021-09-28 隐形的翅膀

    审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0
    经验分享：分享下自己综述的投稿旅程：
    12 Jun 2021：submitted manuscript.
    02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor.
    02 Sep 2021：Interactive review forum activated.
    16 Sep 2021：Submitting Author re-submitted manuscript.
    20 Sep 2021：Review of Review Editor 1 finalized.
    21 Sep 2021：Review of Review Editor 2 finalized.
    27 Sep 2021：Article accepted for publication.
    总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错

    14

    展开14条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2022-05-19 ms4000000327895144

    之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。

    9

    展开9条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1374, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管<br>经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=938, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：心血管;冠心病<br>经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享：分享下自己综述的投稿旅程：<br>12 Jun 2021：submitted manuscript.<br>02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021：Interactive review forum activated.<br>16 Sep 2021：Submitting Author re-submitted manuscript.<br>20 Sep 2021：Review of Review Editor 1 finalized.<br>21 Sep 2021：Review of Review Editor 2 finalized.<br>27 Sep 2021：Article accepted for publication.<br>总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省)]
    2023-05-16 ms9000001815965090 来自陕西省

    请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map